Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 1
2009 1
2013 1
2014 4
2015 3
2016 1
2017 1
2018 3
2019 4
2020 15
2021 22
2022 5
2023 15
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Idiopathic subglottic stenosis: a review.
Aravena C, Almeida FA, Mukhopadhyay S, Ghosh S, Lorenz RR, Murthy SC, Mehta AC. Aravena C, et al. J Thorac Dis. 2020 Mar;12(3):1100-1111. doi: 10.21037/jtd.2019.11.43. J Thorac Dis. 2020. PMID: 32274178 Free PMC article. Review.
No apparent etiology is identified even after a comprehensive workup that includes a complete history, physical examination, pulmonary function testing, auto-antibodies, imaging studies, and endoscopic procedures. This approach, however, helps to exclude other conditions s …
No apparent etiology is identified even after a comprehensive workup that includes a complete history, physical examination, pulmonary funct …
Serological diagnosis of myasthenia gravis and its clinical significance.
Li Y, Peng Y, Yang H. Li Y, et al. Ann Transl Med. 2023 Apr 15;11(7):290. doi: 10.21037/atm-19-363. Epub 2019 Sep 29. Ann Transl Med. 2023. PMID: 37090043 Free PMC article. Review.
Anti-acetylcholine receptor (anti-AChR), anti-muscle-specific kinase (anti-MuSK), and anti-lipoprotein receptor-related protein 4 (anti-LRP4) antibodies are the three well-defined pathogenic antibodies. Patients with MG can also have other antibodies, such as …
Anti-acetylcholine receptor (anti-AChR), anti-muscle-specific kinase (anti-MuSK), and anti-lipoprotein receptor-related protein 4 (anti-LRP4 …
Narrative review of autoantibodies in idiopathic inflammatory myopathies.
Liu Y, Zheng Y, Hao H, Yuan Y. Liu Y, et al. Ann Transl Med. 2023 Apr 15;11(7):291. doi: 10.21037/atm-21-475. Epub 2021 Dec 10. Ann Transl Med. 2023. PMID: 37090051 Free PMC article. Review.
MAAs usually refer to autoantibodies which are also available in systematic autoimmune diseases (anti-PM/SCL, anti-Ku, anti-Ro52 and anti-U1RNP antibodies). MSAs refer to autoantibodies which were distinctive for IIM (anti-Mi-2, anti-MDA5, anti-TIF1gammma, anti-NXP2, anti- …
MAAs usually refer to autoantibodies which are also available in systematic autoimmune diseases (anti-PM/SCL, anti-Ku, anti-Ro52 and anti-U1 …
Detection of anti-ganglioside antibodies in Guillain-Barre syndrome.
Zhu W, Li K, Cui T, Yan Y. Zhu W, et al. Ann Transl Med. 2023 Apr 15;11(7):289. doi: 10.21037/atm-20-2285. Epub 2021 Apr 21. Ann Transl Med. 2023. PMID: 37090048 Free PMC article. Review.
Antibodies binding to gangliosides can activate complement system and recruit macrophages on the axolemma at the nodes of Ranvier of motor fibers, which are found in the course of GBS, causing axonal degeneration and reversible conduction block or conduction failure. ...He …
Antibodies binding to gangliosides can activate complement system and recruit macrophages on the axolemma at the nodes of Ranvier of …
Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor: Addition to the S1 guideline: Therapy of migraine attacks and prevention of migraine. Recommendations of the Germany Society of Neurology and the German Migraine and Headache Society.
Diener HC, Förderreuther S, Gaul C, Giese F, Hamann T, Holle-Lee D, Jürgens TP, Kamm K, Kraya T, Lampl C, May A, Reuter U, Scheffler A, Tfelt-Hansen P. Diener HC, et al. Neurol Res Pract. 2020 Apr 13;2:11. doi: 10.1186/s42466-020-00057-1. eCollection 2020. Neurol Res Pract. 2020. PMID: 33324917 Free PMC article.
Monoclonal antibodies against the calcitonin gene-related peptide (CGRP) receptor (Erenumab) or against CGRP (Eptinezumab, Fremanezumab, Galcanezumab) are new substances for the preventive treatment of migraine. ...This guideline is an abridged and translated version of th …
Monoclonal antibodies against the calcitonin gene-related peptide (CGRP) receptor (Erenumab) or against CGRP (Eptinezumab, Fremanezum …
Autoimmune cerebellar ataxia associated with anti-Purkinje cells antibodies: the next frontier of neuroimmunology.
Zhang W, Ren H, Ren X, Fang F, Guan H. Zhang W, et al. Ann Transl Med. 2023 Apr 15;11(7):285. doi: 10.21037/atm-20-2187. Epub 2021 Jul 21. Ann Transl Med. 2023. PMID: 37090052 Free PMC article. Review.
Technological innovation promotes the rapid development of cerebellar autoimmunity researches in recent years. More and more new antibodies have been proposed to be associated with ACA. Several autoantibodies against Purkinje cells (PCs) have been identified, which constit …
Technological innovation promotes the rapid development of cerebellar autoimmunity researches in recent years. More and more new antibodi …
Is the European Patent Office's approach to assessing obviousness of antibody inventions consistent?
Rigby B. Rigby B. Expert Opin Ther Pat. 2014 Dec;24(12):1283-5. doi: 10.1517/13543776.2014.981255. Expert Opin Ther Pat. 2014. PMID: 25407281
However, in Europe, the bar for assessing the inventiveness (obviousness) of antibodies is currently set particularly high, so there is a significant risk that new antibodies may be denied patent protection despite having beneficial properties. This article looks at …
However, in Europe, the bar for assessing the inventiveness (obviousness) of antibodies is currently set particularly high, so there …
Autoantibodies detection in anti-N-methyl-D-aspartate receptor encephalitis.
Li J, Wang Q, Wang H. Li J, et al. Ann Transl Med. 2023 Apr 15;11(7):284. doi: 10.21037/atm-20-2279. Epub 2021 Jul 9. Ann Transl Med. 2023. PMID: 37090042 Free PMC article. Review.
Besides, more positive samples were found in CSF than in serum by either IHC or CBA. Hence, both serum and CSF should be sent to detect antibodies by two assays to avoid misdiagnosis. CSF antibody titers were believed more clinically relevant. When positive results were sh …
Besides, more positive samples were found in CSF than in serum by either IHC or CBA. Hence, both serum and CSF should be sent to detect a …
Editorial: Immunogenicity of Proteins Used as Therapeutics.
Sauna ZE, Richards SM, Maillere B, Jury EC, Rosenberg AS. Sauna ZE, et al. Front Immunol. 2020 Oct 29;11:614856. doi: 10.3389/fimmu.2020.614856. eCollection 2020. Front Immunol. 2020. PMID: 33193460 Free PMC article. No abstract available.
Current management of gastric adenocarcinoma: a narrative review.
Nevo Y, Ferri L. Nevo Y, et al. J Gastrointest Oncol. 2023 Aug 31;14(4):1933-1948. doi: 10.21037/jgo-22-818. Epub 2023 Aug 10. J Gastrointest Oncol. 2023. PMID: 37720442 Free PMC article. Review.
Targeted therapies in gastric adenocarcinoma include monoclonal antibodies directed against vascular endothelial growth factor (VEGF), vascular endothelial growth factor receptor-2 (VEGFR-2), and human epidermal growth factor receptor 2 (HER2). ...
Targeted therapies in gastric adenocarcinoma include monoclonal antibodies directed against vascular endothelial growth factor (VEGF) …
69 results